AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1
- PMID: 20024838
AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1
Abstract
The 21st international symposium of the American Association for Cancer Research (AACR), the NCI and the European Organization for Research and Treatment of Cancer (EORTC), held in Boston, included topics covering the development of therapeutics and molecular targets in the field of cancer research. This conference report highlights selected presentations on the development of novel drugs for cancer. Investigational drugs discussed include XL-139 (Bristol-Myers Squibb Co/Exelixis Inc), SPC-3042 (Enzon Pharmaceuticals Inc/ Santaris Pharma A/S), CH-5137291 (Chugai Pharmaceutical Co Ltd), SN-29966/SN-29926/SN-3000 (Proacta Inc), withaferin-A (University of Kansas), Reolysin (Oncolytics Biotech Inc), EZN-3889 and EZN-3892 (Enzon Pharmaceuticals/Santaris Pharma), and CBP-501 (CanBas Co Ltd/Takeda Pharmaceutical Co Ltd).
Similar articles
-
AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.IDrugs. 2010 Jan;13(1):10-2. IDrugs. 2010. PMID: 20024839
-
American Diabetes Association--70th scientific sessions--research on novel therapeutics: part 1.IDrugs. 2010 Sep;13(9):595-7. IDrugs. 2010. PMID: 20799136
-
AACR-NCI-EORTC International Conference 2009.Expert Rev Anticancer Ther. 2010 Mar;10(3):319-20. doi: 10.1586/era.10.4. Expert Rev Anticancer Ther. 2010. PMID: 20214512
-
Targeted therapy for thyroid cancer: An updated review of investigational agents.Curr Opin Investig Drugs. 2010 Jun;11(6):661-8. Curr Opin Investig Drugs. 2010. PMID: 20496261 Review.
-
Phosphatases as targets for cancer treatment.Curr Opin Investig Drugs. 2009 Dec;10(12):1297-304. Curr Opin Investig Drugs. 2009. PMID: 19943201 Review.
Cited by
-
Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells.Cancer Sci. 2013 Feb;104(2):143-8. doi: 10.1111/cas.12051. Epub 2012 Dec 7. Cancer Sci. 2013. PMID: 23107437 Free PMC article.
-
Targeting survivin in cancer.Cancer Lett. 2013 May 28;332(2):225-8. doi: 10.1016/j.canlet.2012.03.005. Epub 2012 Mar 9. Cancer Lett. 2013. PMID: 22410464 Free PMC article. Review.
-
Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation.Transl Cancer Res. 2019 Oct;8(6):2449-2460. doi: 10.21037/tcr.2019.09.57. Transl Cancer Res. 2019. PMID: 35116997 Free PMC article.